Mass Spectrometry in GMP Environments: Enhancing QC and Compliance in Drug Development

by AMSbiopharma

Applications of mass spectometry extend far beyond its original role in molecular weight determination. Today, its use span the entire drug development lifecycle, from discovery and preclinical profil...

Read more

How CDMOs With In-House Analytical Capabilities Save Sponsors Risk, Cost, and Time

by 3PBIOVIAN

Analytical services are critical to the development and manufacture of safe and effective biopharmaceuticals. These analytical services often are outsourced to third-party laboratories, and in some ca...

Read more

Project Management in Biologics Development: Keys to Successful CDMO Collaboration

by 53Biologics

Biologics development is complex. Each project involves multiple stakeholders, tight timelines and strict regulatory standards. For companies working with a Contract Development and Manufacturing Orga...

Read more

Palobiofarma announce several important milestones dealing with the clinical development of PBF-999 for Prader-Willi Syndrome

by Palobiofarma

Palobiofarma S.L., una empresa biofarmacéutica dedicada al descubrimiento y desarrollo de fármacos innovadores para enfermedades huérfanas, ha anunciado hoy el logro de varios hitos importantes en ...

Read more

GENESIS Biomed participated in the strategic development of AptaTargets, which has licensed its drug ApTOLL to Merck

by GENESIS Biomed

AptaTargets signed in May 2025 a licensing agreement with Merck for the clinical development and global commercialisation of ApTOLL, an aptamer with neuroprotective effect for the treatment of ischaem...

Read more

ORYZON announces First‑Patient‑In (FPI) in RESTORE Phase Ib trial of iadademstat in sickle cell disease

by Oryzon Genomics

Recently approved by the European Medicines Agency, RESTORE will evaluate iadademstat’s ability to raise fetal hemoglobin (HbF) in adult patients with SCD

Read more

ORYZON announces positive clinical data of iadademstat at ASH-2025

by Oryzon Genomics

Preliminary data from the ongoing Phase Ib trial combining iadademstat with azacitidine and venetoclax in newly diagnosed, unfit AML patients showed a 100% overall response rate

Read more

Una técnica ultrarrápida que combina resonancia magnética con IA agiliza la búsqueda de nuevos fármacos

by CSIC - Centro Superior de Investigaciones Científicas

Un estudio internacional, con participación del Instituto de Investigaciones Químicas del CSIC, logra evaluar 140 moléculas candidatas al día, frente a las 4 a 15 de los métodos actuales

Read more

The FDA approves a treatment co-created at Vall d’Hebron for a rare muscle disease

by Vall d’Hebron

The clinical trial, which also involved Vall d’Hebron, shows that the new therapy improves survival by 86% in patients with thymidine kinase 2 deficiency (TK2d).

Read more

ORYZON reports financial results and corporate update for quarter ended September 30, 2025

by Oryzon Genomics

The net result as of September 30, 2025 improved by $1.1M compared to September 2024, following termination of a Convertible Bonds financing facility with Nice&Green

Read more

The Rise of Autonomous Labs in Life Science

by Sartorius Stedim Spain

Most drug candidates fail in clinical trials. Artificial intelligence and automation promise faster, more targeted, and ultimately more successful drug development. At the Falling Walls Science Summit...

Read more

Optimizing LC‑MS/MS Sensitivity: Strategies to Overcome Ion Suppression and Boost Robustness in Bioanalysis

by AMSbiopharma

This article explores how advanced LC‑MS/MS instrumentation and refined method development approaches can overcome these hurdles, enhancing data quality and operational reliability in bioanalytical ...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Telum Therapeutics Secures €18 Million...

by Telum Therapeutics

Telum Therapeutics, a biotechnology company leveraging proprietary met...

Photos Stream